InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,718.57
(
0.28%
)
US TECH 100
19,295.70
(
-0.01%
)
Dow Jones
42,124.65
(
0.15%
)
Brent Oil
73.74
(
-0.20%
)
Bitcoin
63,283.96
(
-0.54%
)
Post# of 83
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

surf1944

Send PM Follow Ignore
Followers 466
Posts 26938
Boards Moderated 2
Alias Born 09/11/2006

surf1944

Re: surf1944 post# 39

Tuesday, 09/06/2011 11:15:16 AM

Tuesday, September 06, 2011 11:15:16 AM

Post# of 83
7:03AM Auxilium Pharma announced a 17 month safety update of XIAFLEX (AUXL) 16.40 : Auxilium Pharmaceuticals (AUXL) announced a safety update following 17 months of post-approval use in the U.S. of XIAFLEX for the treatment of adult Dupuytren's contracture patients with a palpable cord. After ~11,000 injections administered to ~10,000 patients in the U.S., there was no clinically meaningful change in the nature of events expected relative to the clinical trial safety profile.


surf's up......crikey



Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up